QUES: According to a tradition first reported by Sulcard in about 1080, a church was founded at the site (then known as Thorn Ey (Thorn Island)) in the 7th century, at the time of Mellitus, a Bishop of London. Construction of the present church began in 1245, on the orders of King Henry III.
What is the meaning of Thorn Ey?

ANS: Thorn Island

QUES: Myocardial infarction in the setting of plaque results from underlying atherosclerosis. Inflammation is known to be an important step in the process of atherosclerotic plaque formation. C-reactive protein (CRP) is a sensitive but nonspecific marker for inflammation. Elevated CRP blood levels, especially measured with high-sensitivity assays, can predict the risk of MI, as well as stroke and development of diabetes. Moreover, some drugs for MI might also reduce CRP levels. The use of high-sensitivity CRP assays as a means of screening the general population is advised against, but it may be used optionally at the physician's discretion in those who already present with other risk factors or known coronary artery disease. Whether CRP plays a direct role in atherosclerosis remains uncertain.
The setting of plaque is called what?

ANS: unanswerable

QUES: The leading Cubist architects were Pavel Janak, Josef Gocar, Vlastislav Hofman, Emil Kralicek and Josef Chochol. They worked mostly in Prague but also in other Bohemian towns. The best-known Cubist building is the House of the Black Madonna in the Old Town of Prague built in 1912 by Josef Gocar with the only Cubist cafe in the world, Grand Cafe Orient. Vlastislav Hofman built the entrance pavilions of Dablice Cemetery in 19121914, Josef Chochol designed several residential houses under Vysehrad. A Cubist streetlamp has also been preserved near the Wenceslas Square, designed by Emil Kralicek in 1912, who also built the Diamond House in the New Town of Prague around 1913.
Where is the House of the Black Madonna located?

ANS: Old Town of Prague

QUES: In April 1994, the results of a Merck-sponsored study, the Scandinavian Simvastatin Survival Study, were announced. Researchers tested simvastatin, later sold by Merck as Zocor, on 4,444 patients with high cholesterol and heart disease. After five years, the study concluded the patients saw a 35% reduction in their cholesterol, and their chances of dying of a heart attack were reduced by 42%. In 1995, Zocor and Mevacor both made Merck over US$1 billion. Endo was awarded the 2006 Japan Prize, and the Lasker-DeBakey Clinical Medical Research Award in 2008. For his "pioneering research into a new class of molecules" for "lowering cholesterol,"[sentence fragment]
How much did Zocor reduce the chance of dying from a heart attack?

ANS:
42%